Truvestments Capital LLC Aclaris Therapeutics, Inc. Transaction History
Truvestments Capital LLC
- $252 Million
- Q1 2024
A detailed history of Truvestments Capital LLC transactions in Aclaris Therapeutics, Inc. stock. As of the latest transaction made, Truvestments Capital LLC holds 150 shares of ACRS stock, worth $170. This represents 0.0% of its overall portfolio holdings.
Number of Shares
150
Previous 150
-0.0%
Holding current value
$170
Previous $0
NaN%
% of portfolio
0.0%
Previous 0.0%
Shares
4 transactions
Others Institutions Holding ACRS
# of Institutions
102Shares Held
53.5MCall Options Held
51KPut Options Held
31.6K-
Bml Capital Management, LLC Zionsville, IN9.4MShares$10.7 Million7.8% of portfolio
-
Black Rock Inc. New York, NY5.2MShares$5.93 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.93MShares$5.62 Million0.0% of portfolio
-
D. E. Shaw & Co., Inc. New York, NY3.28MShares$3.74 Million0.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny3.27MShares$3.73 Million0.0% of portfolio
About Aclaris Therapeutics, Inc.
- Ticker ACRS
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 66,671,800
- Market Cap $76M
- Description
- Aclaris Therapeutics, Inc. operates a clinical-stage biopharmaceutical company, develops novel drug candidates for immune-inflammatory diseases in the United States. It operates through two segments: Therapeutics and Contract Research. The Therapeutics segment is involved in identifying and developing innovative therapies to address significant ...